Innovation
in Nucleic Acid Therapeutics for Human Health

Collaborations

  • HOME
  • R & D
  • Collaborations

Research Collaborations

Hugel Inc.
Anti-scar program (OLX101) L/O and Joint Development
University of Virginia School of Medicine (Dr. J Ambati)
Age-related Macular Degeneration program (OLX301) Research Collaboration
ASTAR – IMCB(Singapore)
A*STAR(Singapore)-KHIDI(Korea) Joint Grant Call
Idiopathic Pulmonary Fibrosis (IPF) program (OLX201)
Korea Institute of Toxicology, Department of Inhalation Research
Development Collaboration for Respiratory program (IPF, OLX201)
Ildong Pharmaceutical Co Ltd.
Agreement on collaborative research of AMD treatment with Ildong Pharmaceutical Co Ltd
Covance
Anti-scar program (OLX101) EU clinical trial
NCERP, National Center for Efficacy Evaluation of Respiratory Disease Product
Development Collaboration for pulmonary program
Théa Open Innovation by Laboratories Théa S.A.St
Collaboration and License Agreement for the treatment of AMD (OLX301A)